LIN28B and lung carcinoma: In this study, we discovered that miR-203 directly targets LIN28B in lung cancer cells, thereby disrupting the Lin28/let-7 circuit, enhancing let-7 biogenesis and consequently inhibiting the proliferation and promoting the apoptosis of lung cancer cells.